US$ 22.65
weight watchers with glp 1 WeightWatchers revamps brand identity to better tap into GLP-1 craze WeightWatchers' stock reverses gains despite
Description
2 in 3 adults are uneasy about the necessity for continual use and potential mental health challenges during usage
Regulatory Perspective and Development Context The FDA submission represents a transition from clinical development into regulatory review, not a guarantee of approval
PMID: 37385280.
doi: 10.1345/aph.1H060 [DOI] [PubMed] [Google Scholar] 121
Options include yogurt with live cultures, kefir, kimchi, and sauerkraut
